← All Sponsors
SPONSOR

Pharming Technologies B.V.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: PIDs Linked to PI3K
NCT06990529 Phase 2
Recruiting

Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation

PIDs Linked to PI3K
United States, Spain View Trial →